Voice Analysis in Women With Polycystic Ovary Syndrome
1 other identifier
observational
50
0 countries
N/A
Brief Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to one in five reproductive-aged women. It is associated with clinical and/or biochemical hyperandrogenism, oligomenorrhea, and polycystic appearance of ovaries in ultrasonography. Voice changes have been traditionally recognized as a feature of PCOS for years. However, voice analyses of patients with PCOS are limited. The human larynx is a highly hormone-sensitive target with the presence of hormonal receptors within the vocal folds, and vocal changes occur in relation to the fluctuations in the sex hormones. During the reproductive years and throughout the menstrual cycle, vocal changes have been reported in almost one-third of nonprofessional voice users.The aim of this work is to evaluate the voice characteristics among women with PCOS
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 20, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedOctober 16, 2023
October 1, 2023
1 month
August 20, 2023
October 12, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
frequency
frequency in hertz
baseline
jitter
jitter in percentage%
baseline
shimmer
shimmer in decibel
baseline
Harmonic to noise ratio
Harmonic to noise ratio in decibel
baseline
Study Arms (2)
Group I
Group I (women with PCOs on ultrasound)
Group II
group II(Group II will be women rated to have a normal voice as assessed using Auditory-Perceptual Evaluation of Voice, these women have a regular menstrual cycles and no PCOS on ultrasound)
Interventions
Acoustic measurements: Acoustic analysis using Multidimensional voice program software (MDVP) will be carried out with the sustained /a/vowel for 9 seconds, for measuring frequency, jitter, shimmer and harmonic to noise ratio of the voice
Eligibility Criteria
50 women with and without PCOS They will divided into 2 groups. Group I will comprise of the 25 women in the clinical group diagnosed with PCOS on ultrasound, while Group II will comprise of 25 typical women as controls
You may qualify if:
- Group I participants:
- women with polycystic ovaries on ultrasound.
- Group II will be:
- women have a regular menstrual cycles and no PCOS on ultrasound
You may not qualify if:
- Women with hypersensitive gag reflex,
- alcohol consumption,
- Smoking,
- reflux symptoms and vocal abuse will be excluded in both groups.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Related Publications (2)
Hannoun A, Zreik T, Husseini ST, Mahfoud L, Sibai A, Hamdan AL. Vocal changes in patients with polycystic ovary syndrome. J Voice. 2011 Jul;25(4):501-4. doi: 10.1016/j.jvoice.2009.12.005. Epub 2010 May 26.
PMID: 20537860BACKGROUNDAydin K, Akbulut S, Demir MG, Demir S, Ozderya A, Temizkan S, Sargin M. Voice characteristics associated with polycystic ovary syndrome. Laryngoscope. 2016 Sep;126(9):2067-72. doi: 10.1002/lary.25818. Epub 2015 Dec 23.
PMID: 26700739RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hany G Eissawy, MD
Minia University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 20, 2023
First Posted
October 16, 2023
Study Start
December 1, 2023
Primary Completion
January 1, 2024
Study Completion
February 1, 2024
Last Updated
October 16, 2023
Record last verified: 2023-10